The Problem inherent with using Cord Blood in the treatment of leukemia injection is a relatively small number of stem cells in the standard cord blood samples; Therefore, to date, has the greatest potential of Cord Blood has been limited to children or small adults. The ability to expand the number of stem cells in Cord Blood, however, comes the expanded treatment options in the greater part of the population.
Results from studies Hutch 10 Leukemia patients show that aid blood stem cells extended the cord is not only safe, but also effectively cut the time to engraftment by half compared to the stem cells of the blood-manipulate the cord. Motto: faster engraftment takes place, the better a patient's chance of survival. Seven study 10 patients are still alive today and show no signs of disease.Cord blood is still a promising alternative to bone marrow transplant, are less susceptible to "graft vs. host disease and other complications for the recipient of the rejection of foreign cells, and do not require a perfect donor. In the previous blog entry, we reported on a similar process extension cord blood stem cell population, using the carlecortemcel-l (aka StemEx), published by the University of Texas m. d. Anderson Cancer Center in Houston. While the need for supplementary studies in order to fully realise the results of constant news of these events is encouraging and exciting – both to us at NECBB, and for families, have Blood cord in the future.
Be the first to like this post.Tags: engraftment, studies of human leukemiaThis entry was posted on January 13, 2010 at 7: 22 pm and is filed under the cord blood research. You can track any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback your own site.
No comments:
Post a Comment